New advances in the treatment of adult chronic immune thrombocytopenic purpura: role of thrombopoietin receptor-stimulating agents
Ara Metjian1, Charles S Abrams21Department of Medicine, Duke University Medical Center, Durham, NC, USA; 2Department of Medicine, University of Pennsylvania, Philadelphia, PA, USAAbstract: Decades of basic science and clinical research have led to an increased understanding of the pathophysiology of...
Main Authors: | Ara Metjian, Charles S Abrams |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2009-12-01
|
Series: | Biologics : Targets & Therapy |
Online Access: | http://www.dovepress.com/new-advances-in-the-treatment-of-adult-chronic-immune-thrombocytopenic-a3803 |
Similar Items
-
Pharmacoeconomic analysis of thrombopoietin receptor agonists in the treatment of chronic idiopathic thrombocytopenic purpura in adults
by: E. A. Pyadushkina, et al.
Published: (2018-06-01) -
Caplacizumab in adult patients with acquired thrombotic thrombocytopenic purpura
by: Ashley Hanlon, et al.
Published: (2020-02-01) -
CLINICAL AND ECONOMIC EVALUATION OF THROMBOPOIETIN RECEPTOR AGONISTS IN THE TREATMENT OF CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA IN ADULTS
by: E. A. Pyadushkina, et al.
Published: (2016-02-01) -
A review of immune thrombocytopenic purpura: focus on the novel thrombopoietin agonists
by: Meaghan Khan, et al.
Published: (2010-03-01) -
Pharmacoeconomic Analysis of the Use of Thrombopoietin Receptors Agonists in Idiopathic Thrombocytopenic Purpura Therapy
by: VA Shuvaev, et al.
Published: (2017-10-01)